Interstitial Lung Disease (ILD), also known as Diffuse Parenchymal Lung Disease (DPLD) refers to a group of lung diseases affecting the interstitium (the tissue and space around the air sacs of the lungs). The terms ILD is used to distinguish these diseases from obstructive airways diseases. ILD is not a single disease, but encompasses many different pathological processes. Hence the treatment is different for each disease.
|ARIEL||Interstitial lung disease (ILD) is a chronic lung condition that causes stiff lungs and restricts sufferers from taking a deep breath. Exercise in a gym, or swimming, walking or riding…|
Interested to participate in a study investigating the effect of fatigue on driving performance?
Interstitial lung disease (ILD) is a chronic lung condition that causes stiff lungs and restricts sufferers from taking a deep breath. Exercise in a gym, or swimming, walking or riding a bike, can help...
Sleep apnea is a condition where breathing is abnormal during sleep. There are two main forms of sleep apnea: obstructive and central. For obstructive sleep apnea, breathing is reduced because the airway...
Congratulations Anne Holland for winning the ERS Mid-Career Gold Medal for Allied Health Professionals in recognition of her potential for further outstanding research within a field of the allied health professions. Well Done Anne!
Congratulations to the following IBAS staff members who have been successful in obtaining research funding from the Austin Medical Research Foundation (AMRF) for 2022.
Honouring a legacy: The prestigious 2021 Rob Pierce Grant in Aid is awarded to Dr Marnie Graco, a physiotherapist and implementation scientist from IBAS.
Dr Anna Ridgers, Respiratory and Sleep Physician and IBAS Associate Researcher, has been awarded best oral presentation at the TSANZ annual scientific meeting in the interventional pulmonology category.